News | April 14, 2009

Biotronik Announces First U.S. Implant Of Lumax 540 Series for Heart Failure Patients

April 14, 2009 - Biotronik Inc. announced yesterday the first U.S. implant of the next-generation Lumax 540 Series defibrillator for treating patients with heart failure.

The Lumax 540 Series was recently approved by the FDA.

The first U.S. implant of the new Lumax 540 Series was performed by Leon Feldman, M.D., FACC, co-director of electrophysiology and cardiology section chief at Eisenhower Medical Center in Rancho Mirage, Calif.

“The patient presented with very complex needs: ongoing bradycardia, recurrent ventricular tachycardia, and progressive heart failure all at once,” Dr. Feldman said. “The patient will benefit from the advanced capabilities of the Lumax 5 Series defibrillator.”

Heart failure is on the rise in the U.S., affecting 5 million people with 550,000 new cases each year. Fortunately, therapies are available to enhance the quality of life of a heart failure patient.

“The patient already received the highest dose of beta blockers and ACE inhibitors that he could handle and was still in severe heart failure,” Dr. Feldman said, who said a cardiac resynchronization therapy defibrillator (CRT-D) was the perfect solution. “I’ve had great success with previous-generation Biotronik devices and have confidence in the construction of the device and lead technology. Also, I’m a big proponent of Home Monitoring for the patient, which can remotely and rapidly detect onset of atrial fibrillation, for which this patient is at risk.”

Dr. Feldman said the benefits that Biotronik's Home Monitoring system offers him and the patient early notification of VF and VT, which allows him to modify therapy and avoid unnecessary shocks.

For more information: www.biotronik.com

Related Content

Medtronic Begins Pilot Study of Investigational Extravascular ICD System
News | Implantable Cardioverter Defibrillator (ICD) | August 09, 2018
Medtronic plc announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter...
ICD Placements Not Meeting Medicare Coverage Criteria Decline After Overuse Investigation Announced
Feature | Implantable Cardioverter Defibrillator (ICD) | July 11, 2018
Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and Medicaid Services (CMS...
New Tool Predicts Benefits and Risks of Implantable Defibrillator for Heart Failure Patients
News | Implantable Cardioverter Defibrillator (ICD) | July 02, 2018
University of Washington (UW) Medicine cardiologists have developed a tool to predict which heart-failure patients...
Real-World Data Demonstrates Success Of Smart Pass Filter on Boston Scientific S-ICD System
News | Implantable Cardioverter Defibrillator (ICD) | May 16, 2018
Boston Scientific announced results from an analysis of the LATITUDE database evaluating the successful reduction of...
Online Message Board Advice on ICDs Reflects Inaccuracies
News | Implantable Cardioverter Defibrillator (ICD) | April 13, 2018
April 13, 2018 — Medical advice about implanted cardiac defibrillators obtained via an online message board appears t
Biotronik U.S. to Distribute Aziyo ECM Envelopes
News | Implantable Cardioverter Defibrillator (ICD) | April 12, 2018
Biotronik U.S. and Aziyo announced a strategic agreement allowing Biotronik to distribute Aziyo's CanGaroo...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD) | September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD) | September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD) | July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Videos | Implantable Cardioverter Defibrillator (ICD) | June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Overlay Init